unknown
Stage
2019
Founded
1
Investors
About
Capsida Bio engineers novel adeno-associated viruses (AAVs) and develops targeted gene therapies for neurological and ocular diseases using advanced capsid engineering and preclinical screening technologies.
Explore Capsida Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.